By: Luv_2_Daytrade $$$$
22 Dec 2001, 08:40 PM EST Msg. 27577 of 27581
ragingbull.lycos.com
>>GMED INTERVIEW<<
SARASOTA, Fla., Dec 11, 2001 (BUSINESS WIRE) -- GenoMed Inc.-- ("the Company" or "GenoMed") (Pink Sheets:GMED), a St. Louis, Missouri based medical genomics biotechnology company, announced today that its Founder and Chief Medical Officer, Dr. David Moskowitz is featured on Wall Street Reporter (http://www.wallstreetreporter.com) discussing GenoMed's foray into disease gene discovery.
In describing the company's focus, Dr. Moskowitz states, "We are looking in the part of the genome that, up until now, has been overlooked. We are fishing for disease genes using our DiseaseGeneNet with the intent of compiling this information on our proprietary HealthChip. This will essentially allow us to tell a person's genetic fortune. Once we can tell someone's predisposition to a disease, we can give them medication specifically targeted against their disease process. It is clear, by targeting a gene or group of genes early in the disease process, we can play a major role in delaying the course of disease or even preventing it altogether."
In reference to the profit potential of disease gene discovery, Dr. Moskowitz goes on to say, "The Return on Investment in this particular area is astronomical. We plan to increase shareholder value by continuing to build our intellectual property portfolio. We believe that what is taking place in medical genomics is essentially a land grab and we intend to patent as many disease associated genes as possible in the next 24 months. It is estimated by Daniel Cohen of Genset that a single disease gene is worth from 40 to 80 million dollars, and we expect to find hundreds of these. Because we have one foot firmly in the clinic and the other foot in state of the art genomics, we expect to be the leader in this new translational period which amounts to a revolutionary period in medicine."
DISCLAIMER, PLEASE READ
I HAVE PURCHASED FROM A THIRD PARTY 3,000,000 SHARES OF GMED AT 2c A SHARE, AND BOUGHT 300,000 IN THE OPEN MARKET BETWEEN 8c - 8.5c |
